Psychopharmacological therapies in dermatology

Dermatology Online Journal

Volumn 19, Issue 5, 2013, Pages

  Wong, Jillian W ^a,b   Koo, John Y M ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Psychocutaneous medicine; Psychodermatology; Psychopharmacology

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CITALOPRAM; DIPHENHYDRAMINE; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; HYDROXYZINE; OLANZAPINE; PAROXETINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

AGITATION; ANOREXIA; ANTICHOLINERGIC SYNDROME; ANXIETY; ANXIETY DISORDER; ATRIOVENTRICULAR BLOCK; BEDTIME DOSAGE; BLURRED VISION; CONSTIPATION; DELUSIONAL DISORDER; DEPRESSION; DERMATOLOGIST; DERMATOLOGY; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DRUG FORMULATION; DRUG INDUCED HEADACHE; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HUMAN; IMMEDIATE RELEASE FORMULATION; INSOMNIA; LOW DRUG DOSE; MENTAL DISEASE; MORNING DOSAGE; MUSCLE RIGIDITY; NAUSEA; NERVOUSNESS; OBSESSIVE COMPULSIVE DISORDER; ORTHOSTATIC HYPOTENSION; PRIMARY PSYCHIATTRIC DISEASE; PRURITUS; PSYCHODERMATOLOGICAL DISEASE; PSYCHOPHYSIOLOGICAL DISEASE; QT PROLONGATION; RESTLESSNESS; REVIEW; RHINITIS; SECONDARY PSYCHIATTRIC DISEASE; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; SUSTAINED RELEASE FORMULATION; SWEATING; TARDIVE DYSKINESIA; TREMOR; URINE RETENTION; URTICARIA; WEIGHT GAIN; XEROSTOMIA;

EID: 84877887635     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983; 143: 51-4. [PMID: 6882992]
2. Fried R. Nonpharmacological treatments in psychodermatology. In: Koo J, Lee CS, eds. Psychocutaneous medicine. New York: Marcel Dekker; 2003. p. 411-26.
3. Friedel RO, Raskind MA. Relationship of blood levels of Sinequan to clinical effects in the treatment of depression in aged patients. In: Mendels J, ed. A monograph of recent clinical studies. Lawrenceville, NJ: Excerpta Medica, 1975.
4. Silverstone PH, Ravindran A for the Venlafaxine XR 360 Canadian Study Group. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. J Clin Psychiatry 1999; 60: 22-8. [PMID: 10074873]
5. Rickels K, Pollack MH, Sheehan DV, et al. Efficacy of extended-release Venlafaxine in nondepressed outpatients with generalize anxiety disorder. Am J Psychiatry 2000; 157: 968-74. [PMID: 10831478]
6. Davidson JR, DuPont RL, Hedges D, et al. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 1999; 60: 528-35. [PMID: 10485635]
7. Gelenberg AJ, Lydiard RB, Rudolph RL, et al. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial. JAMA 2000; 238: 3052-88. [PMID: 10865302]
8. Montgomery SA. Venlafaxine: a new dimension in antidepressant pharmacotherapy. J Clin Psychiatry 1998; 59 (Suppl 16): 25-30. [PMID: 8468312]
9. Richelson E. Biological basis of depression and therapeutic relevance. J clin Psychiatry 1991; 52 (Suppl): 4-10. [PMID: 1646793]
10. Modell JG, Katholi CR, Modell JD, et al. Comparative sexual side effects of buproprion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther 1997; 61: 476-87. [PMID: 9129565]
11. Kavoussi RJ, Segraves RT, Hughes AR, et al. Double-blind comparison of buproprion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 1997; 58: 532-7. [PMID: 9448656]
12. Ware JC, McBrayer R, Rose V. REM sleep enhancement by nefazodone, trazadone, and buspirone. Sleep Res 1993; 22:51. [PMID: 7809568]
13. Nofzinger EA, Reynolds III CF, Thase ME, et al. REM sleep enhancement by buproprion in depressed men. Am J Psychiatry 1995; 152: 274-6. [PMID: 7840365]
14. Davidson J. Seizures and buproprion: a review. J Clin Psychiatry 1989; 50: 256-61. [PMID: 2500425]
15. Pollack MH, Zaninelli R, Goddard A, et al. Paroxetine in the treatment of generalized anxiety disorder: results in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001; 62: 350-7. [PMID: 11411817]
16. Haskell DS, Gambill JD, Gardos G, et al. Doxepin or diazepam for anxious and anxious-depressed outpatients? J Clin Psychiatry 1978; 39: 135-9. [PMID: 344303]
17. Meltzer HY. New drugs for the treatment of schizophrenia. Psychiatr Clin North Am 1993; 16: 365-85. [PMID: 8101373]
18. Deutch AY, Moghaddam B, Innis RB, et al. Mechanisms of action of atypical antipsychotic drugs: implications for novel therapeutic strategies for schizophrenia. Schizophr Res 1991; 4: 121-56. [PMID: 1674882]
19. Gerlach J. New antipsychotics: classifications, efficacy, and adverse effects. Schizophr Bull 1991; 17: 289-309. [PMID: 1715608]
20. Davis KL, Kahn RS, Ko G, et al. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991; 148: 1474-86. [PMID: 1681750]
21. Casey DE. Side effect profiles of new antipsychotic agents. J Clin Psychiatry 1996; 57 (Suppl 11): 40S-5S. [PMID: 8941170]
22. Hansen TE, Casey DE, Hoffman WF. Neuroleptic intolerance. Schizophr Bull 1997; 23: 567-82. PMID: 9365996.
23. Rasmussen SA, Eisen JL. Treatment strategies for chronic and refractory obsessive-compulsive disorder. J Clin Psychiatr 1997;58 (Suppl 13): 9-13. [PMID: 10986722]
24. Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32: 671-3. [PMID: 6283422]
25. Max MB, Schafer SC, Culnane M, et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38: 1427-32. [PMID: 3412591]
26. Watson CPN, Chipman M, Reed K, et al. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized double-blind crossover trial. Pain 1992; 48: 29-36. [PMID: 1738571]
27. Freinmann C, Harris M, Cawley R. Psychogenic facial pain: presentation and treatment. BMJ 1984; 288: 436-8. [PMID: 6419955]
28. Urban BJ, France FD, Steinberger EK, et al. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain 1986; 24: 191-6. [PMID: 2870454]
29. Eberhard G, von Knorring L, Nilsson HL, et al. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes. Neuropsychobiology 1988; 19: 25-34. [PMID: 3054623]